Literature DB >> 28368291

Glucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets.

Kathrin Maedler, Pavel Sergeev, Frédéric Ris, José Oberholzer, Helen I Joller-Jemelka, Giatgen A Spinas, Nurit Kaiser, Philippe A Halban, Marc Y Donath.   

Abstract

Entities:  

Year:  2017        PMID： 28368291      PMCID： PMC5373884          DOI： 10.1172/JCI92172

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  1 in total

1.  FLIP switches Fas-mediated glucose signaling in human pancreatic beta cells from apoptosis to cell replication.

Authors:  Kathrin Maedler; Adriano Fontana; Frédéric Ris; Pavel Sergeev; Christian Toso; José Oberholzer; Roger Lehmann; Felix Bachmann; Andrea Tasinato; Giatgen A Spinas; Philippe A Halban; Marc Y Donath
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-11       Impact factor: 11.205
  1 in total
  18 in total

1.  A polysaccharide extract from the medicinal plant Maidong inhibits the IKK-NF-κB pathway and IL-1β-induced islet inflammation and increases insulin secretion.

Authors:  Dandan Mao; Xiao Yu Tian; Di Mao; Sze Wan Hung; Chi Chiu Wang; Clara Bik San Lau; Heung Man Lee; Chun Kwok Wong; Elaine Chow; Xing Ming; Huanyi Cao; Ronald C Ma; Paul K S Chan; Alice P S Kong; Joshua J X Li; Guy A Rutter; Wing Hung Tam; Juliana C N Chan
Journal:  J Biol Chem       Date:  2020-06-30       Impact factor: 5.157

Review 2.  Targeting Islets: Metabolic Surgery Is More than a Bariatric Surgery.

Authors:  Xi Chen; Jingjing Zhang; Zhiguang Zhou
Journal:  Obes Surg       Date:  2019-09       Impact factor: 4.129

Review 3.  Targeting pancreatic β cells for diabetes treatment.

Authors:  Chirag Jain; Sara Bilekova; Heiko Lickert
Journal:  Nat Metab       Date:  2022-09-21

Review 4.  Advances in Glycolysis Metabolism of Atherosclerosis.

Authors:  Ruhan Xu; Wei Yuan; Zhongqun Wang
Journal:  J Cardiovasc Transl Res       Date:  2022-09-06       Impact factor: 3.216

5.  Effect of Mild Physiologic Hyperglycemia on Insulin Secretion, Insulin Clearance, and Insulin Sensitivity in Healthy Glucose-Tolerant Subjects.

Authors:  Aurora Merovci; Devjit Tripathy; Xi Chen; Ivan Valdez; Muhammad Abdul-Ghani; Carolina Solis-Herrera; Amalia Gastaldelli; Ralph A DeFronzo
Journal:  Diabetes       Date:  2020-10-08       Impact factor: 9.461

Review 6.  NLRP3 Inflammasome at the Interface of Inflammation, Endothelial Dysfunction, and Type 2 Diabetes.

Authors:  Ilona M Gora; Anna Ciechanowska; Piotr Ladyzynski
Journal:  Cells       Date:  2021-02-03       Impact factor: 6.600

7.  The oxylipin profile is associated with development of type 1 diabetes: the Diabetes Autoimmunity Study in the Young (DAISY).

Authors:  Teresa Buckner; Lauren A Vanderlinden; Brian C DeFelice; Patrick M Carry; Katerina Kechris; Fran Dong; Oliver Fiehn; Brigitte I Frohnert; Michael Clare-Salzler; Marian Rewers; Jill M Norris
Journal:  Diabetologia       Date:  2021-04-24       Impact factor: 10.460

Review 8.  Diabetes and Sepsis: Risk, Recurrence, and Ruination.

Authors:  Lynn M Frydrych; Fatemeh Fattahi; Katherine He; Peter A Ward; Matthew J Delano
Journal:  Front Endocrinol (Lausanne)       Date:  2017-10-30       Impact factor: 5.555

9.  An 8-week diet high in cereal fiber and coffee but free of red meat does not improve beta-cell function in patients with type 2 diabetes mellitus: a randomized controlled trial.

Authors:  Yanislava Karusheva; Lejla Kunstein; Alessandra Bierwagen; Bettina Nowotny; Stefan Kabisch; Jan B Groener; Ann Kristin Fleitmann; Christian Herder; Giovanni Pacini; Klaus Strassburger; Hans-Ulrich Häring; Peter P Nawroth; Andreas F H Pfeiffer; Volker Burkart; Karsten Müssig; Michael Roden; Julia Szendroedi
Journal:  Nutr Metab (Lond)       Date:  2018-12-29       Impact factor: 4.169

10.  Tumor-secreted factors induce IL-1β maturation via the glucose-mediated synergistic axis of mTOR and NF-κB pathways in mouse macrophages.

Authors:  Yunseo Woo; Hyeran Kim; Keun-Cheol Kim; Jeong A Han; Yu-Jin Jung
Journal:  PLoS One       Date:  2018-12-26       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.